Capstone Therapeutics Corp. 4
4 · Capstone Therapeutics Corp. · Filed Oct 19, 2012
Insider Transaction Report
Form 4
HOLLIMAN JOHN M III
DirectorExecutive Chairman
Transactions
- Purchase
Common Stock
2012-10-18$0.14/sh+100,000$14,000→ 432,614 total - Purchase
Common Stock
2012-10-19$0.14/sh+50,000$7,000→ 482,614 total
Holdings
- 3,000(indirect: By Trust)
Common Stock
- 1,658(indirect: Valley Ventures III, L.P.)
Common Stock